Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,861
archived clinical trials in
Bladder Cancer

Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter
A Phase II Study of PS-341 in Advanced or Metastatic Urothelial Cancer (Transitional Cell Cancer of the Bladder, Ureter, and Renal Pelvis)
Status: Enrolling
Updated:  7/22/2015
Central Illinois Hematology Oncology Center
351
mi
from 43215
Springfield, IL
Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter
A Phase II Study of PS-341 in Advanced or Metastatic Urothelial Cancer (Transitional Cell Cancer of the Bladder, Ureter, and Renal Pelvis)
Status: Enrolling
Updated: 7/22/2015
Central Illinois Hematology Oncology Center
351
mi
from 43215
Springfield, IL
Click here to add this to my saved trials
Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter
A Phase II Study of PS-341 in Advanced or Metastatic Urothelial Cancer (Transitional Cell Cancer of the Bladder, Ureter, and Renal Pelvis)
Status: Enrolling
Updated:  7/22/2015
Fort Wayne Medical Oncology and Hematology
137
mi
from 43215
Fort Wayne, IN
Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter
A Phase II Study of PS-341 in Advanced or Metastatic Urothelial Cancer (Transitional Cell Cancer of the Bladder, Ureter, and Renal Pelvis)
Status: Enrolling
Updated: 7/22/2015
Fort Wayne Medical Oncology and Hematology
137
mi
from 43215
Fort Wayne, IN
Click here to add this to my saved trials
Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter
A Phase II Study of PS-341 in Advanced or Metastatic Urothelial Cancer (Transitional Cell Cancer of the Bladder, Ureter, and Renal Pelvis)
Status: Enrolling
Updated:  7/22/2015
CCOP - Northern Indiana CR Consortium
205
mi
from 43215
South Bend, IN
Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter
A Phase II Study of PS-341 in Advanced or Metastatic Urothelial Cancer (Transitional Cell Cancer of the Bladder, Ureter, and Renal Pelvis)
Status: Enrolling
Updated: 7/22/2015
CCOP - Northern Indiana CR Consortium
205
mi
from 43215
South Bend, IN
Click here to add this to my saved trials
Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter
A Phase II Study of PS-341 in Advanced or Metastatic Urothelial Cancer (Transitional Cell Cancer of the Bladder, Ureter, and Renal Pelvis)
Status: Enrolling
Updated:  7/22/2015
Oncology Care Associates, PLLC
231
mi
from 43215
Saint Joseph, MI
Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter
A Phase II Study of PS-341 in Advanced or Metastatic Urothelial Cancer (Transitional Cell Cancer of the Bladder, Ureter, and Renal Pelvis)
Status: Enrolling
Updated: 7/22/2015
Oncology Care Associates, PLLC
231
mi
from 43215
Saint Joseph, MI
Click here to add this to my saved trials
Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter
A Phase II Study of PS-341 in Advanced or Metastatic Urothelial Cancer (Transitional Cell Cancer of the Bladder, Ureter, and Renal Pelvis)
Status: Enrolling
Updated:  7/22/2015
Medical College of Wisconsin Cancer Center
335
mi
from 43215
Milwaukee, WI
Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter
A Phase II Study of PS-341 in Advanced or Metastatic Urothelial Cancer (Transitional Cell Cancer of the Bladder, Ureter, and Renal Pelvis)
Status: Enrolling
Updated: 7/22/2015
Medical College of Wisconsin Cancer Center
335
mi
from 43215
Milwaukee, WI
Click here to add this to my saved trials
Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter
A Phase II Study of PS-341 in Advanced or Metastatic Urothelial Cancer (Transitional Cell Cancer of the Bladder, Ureter, and Renal Pelvis)
Status: Enrolling
Updated:  7/22/2015
Margaret and Charles Juravinski Cancer Centre
279
mi
from 43215
Hamilton,
Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter
A Phase II Study of PS-341 in Advanced or Metastatic Urothelial Cancer (Transitional Cell Cancer of the Bladder, Ureter, and Renal Pelvis)
Status: Enrolling
Updated: 7/22/2015
Margaret and Charles Juravinski Cancer Centre
279
mi
from 43215
Hamilton,
Click here to add this to my saved trials
Prostate Capsule Sparing Cystectomy and Nerve-sparing Radical Cystoprostatectomy in Men With Bladder Cancer
Prospective Phase II Randomized Trial of Prostate Capsule Sparing Cystectomy and Nerve-sparing Radical Cystoprostatectomy in Men With Bladder Cancer
Status: Enrolling
Updated:  8/17/2015
University of Michigan
164
mi
from 43215
Ann Arbor, MI
Prostate Capsule Sparing Cystectomy and Nerve-sparing Radical Cystoprostatectomy in Men With Bladder Cancer
Prospective Phase II Randomized Trial of Prostate Capsule Sparing Cystectomy and Nerve-sparing Radical Cystoprostatectomy in Men With Bladder Cancer
Status: Enrolling
Updated: 8/17/2015
University of Michigan
164
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Bupropion in Helping Adults Stop Smoking
A Phase II Study of the Effects of Extended Pre-Cessation Bupropion for Smoking Cessation
Status: Enrolling
Updated:  8/27/2015
Roswell Park Cancer Institute
295
mi
from 43215
Buffalo, NY
Bupropion in Helping Adults Stop Smoking
A Phase II Study of the Effects of Extended Pre-Cessation Bupropion for Smoking Cessation
Status: Enrolling
Updated: 8/27/2015
Roswell Park Cancer Institute
295
mi
from 43215
Buffalo, NY
Click here to add this to my saved trials
Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treatment of Advanced Urothelial Cancer
ABX209: Phase II Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treatment of Advanced Urothelial Cancer.
Status: Enrolling
Updated:  8/28/2015
University of Michigan Comprehensive Cancer Center
164
mi
from 43215
Ann Arbor, MI
Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treatment of Advanced Urothelial Cancer
ABX209: Phase II Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treatment of Advanced Urothelial Cancer.
Status: Enrolling
Updated: 8/28/2015
University of Michigan Comprehensive Cancer Center
164
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and Survivors
Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and Survivors
Status: Enrolling
Updated:  8/28/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and Survivors
Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and Survivors
Status: Enrolling
Updated: 8/28/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Phase II Randomized Trial of Gemcitabine and Cisplatin With or Without Cetuximab in Patients With Urothelial Carcinoma
Status: Enrolling
Updated:  8/28/2015
City of Hope Cancer Center
1955
mi
from 43215
Duarte, CA
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Phase II Randomized Trial of Gemcitabine and Cisplatin With or Without Cetuximab in Patients With Urothelial Carcinoma
Status: Enrolling
Updated: 8/28/2015
City of Hope Cancer Center
1955
mi
from 43215
Duarte, CA
Click here to add this to my saved trials
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Phase II Randomized Trial of Gemcitabine and Cisplatin With or Without Cetuximab in Patients With Urothelial Carcinoma
Status: Enrolling
Updated:  8/28/2015
Kenneth J. Norris Jr. Comprehensive Cancer Center, Keck School of Medicine, University of Southern California
1970
mi
from 43215
Los Angeles, CA
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Phase II Randomized Trial of Gemcitabine and Cisplatin With or Without Cetuximab in Patients With Urothelial Carcinoma
Status: Enrolling
Updated: 8/28/2015
Kenneth J. Norris Jr. Comprehensive Cancer Center, Keck School of Medicine, University of Southern California
1970
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Phase II Randomized Trial of Gemcitabine and Cisplatin With or Without Cetuximab in Patients With Urothelial Carcinoma
Status: Enrolling
Updated:  8/28/2015
Stanford University
2100
mi
from 43215
Stanford, CA
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Phase II Randomized Trial of Gemcitabine and Cisplatin With or Without Cetuximab in Patients With Urothelial Carcinoma
Status: Enrolling
Updated: 8/28/2015
Stanford University
2100
mi
from 43215
Stanford, CA
Click here to add this to my saved trials
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Phase II Randomized Trial of Gemcitabine and Cisplatin With or Without Cetuximab in Patients With Urothelial Carcinoma
Status: Enrolling
Updated:  8/28/2015
Robert H. Lurie Comprehensive Cancer Center, Center of Northwestern University
274
mi
from 43215
Chicago, IL
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Phase II Randomized Trial of Gemcitabine and Cisplatin With or Without Cetuximab in Patients With Urothelial Carcinoma
Status: Enrolling
Updated: 8/28/2015
Robert H. Lurie Comprehensive Cancer Center, Center of Northwestern University
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Phase II Randomized Trial of Gemcitabine and Cisplatin With or Without Cetuximab in Patients With Urothelial Carcinoma
Status: Enrolling
Updated:  8/28/2015
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
345
mi
from 43215
Baltimore, MD
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Phase II Randomized Trial of Gemcitabine and Cisplatin With or Without Cetuximab in Patients With Urothelial Carcinoma
Status: Enrolling
Updated: 8/28/2015
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
345
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Phase II Randomized Trial of Gemcitabine and Cisplatin With or Without Cetuximab in Patients With Urothelial Carcinoma
Status: Enrolling
Updated:  8/28/2015
Boston Med Ctr
642
mi
from 43215
Boston, MA
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Phase II Randomized Trial of Gemcitabine and Cisplatin With or Without Cetuximab in Patients With Urothelial Carcinoma
Status: Enrolling
Updated: 8/28/2015
Boston Med Ctr
642
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Phase II Randomized Trial of Gemcitabine and Cisplatin With or Without Cetuximab in Patients With Urothelial Carcinoma
Status: Enrolling
Updated:  8/28/2015
Lahey Clinic
638
mi
from 43215
Burlington, MA
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Phase II Randomized Trial of Gemcitabine and Cisplatin With or Without Cetuximab in Patients With Urothelial Carcinoma
Status: Enrolling
Updated: 8/28/2015
Lahey Clinic
638
mi
from 43215
Burlington, MA
Click here to add this to my saved trials
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Phase II Randomized Trial of Gemcitabine and Cisplatin With or Without Cetuximab in Patients With Urothelial Carcinoma
Status: Enrolling
Updated:  8/28/2015
University of Michigan
164
mi
from 43215
Ann Arbor, MI
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Phase II Randomized Trial of Gemcitabine and Cisplatin With or Without Cetuximab in Patients With Urothelial Carcinoma
Status: Enrolling
Updated: 8/28/2015
University of Michigan
164
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Phase II Randomized Trial of Gemcitabine and Cisplatin With or Without Cetuximab in Patients With Urothelial Carcinoma
Status: Enrolling
Updated:  8/28/2015
Wayne State University/Karmanos Cancer Institute
164
mi
from 43215
Detroit, MI
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Phase II Randomized Trial of Gemcitabine and Cisplatin With or Without Cetuximab in Patients With Urothelial Carcinoma
Status: Enrolling
Updated: 8/28/2015
Wayne State University/Karmanos Cancer Institute
164
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Phase II Randomized Trial of Gemcitabine and Cisplatin With or Without Cetuximab in Patients With Urothelial Carcinoma
Status: Enrolling
Updated:  8/28/2015
Roswell Park Cancer Institute
295
mi
from 43215
Buffalo, NY
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Phase II Randomized Trial of Gemcitabine and Cisplatin With or Without Cetuximab in Patients With Urothelial Carcinoma
Status: Enrolling
Updated: 8/28/2015
Roswell Park Cancer Institute
295
mi
from 43215
Buffalo, NY
Click here to add this to my saved trials
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Phase II Randomized Trial of Gemcitabine and Cisplatin With or Without Cetuximab in Patients With Urothelial Carcinoma
Status: Enrolling
Updated:  8/28/2015
Vanderbilt-Ingram Cancer Center
334
mi
from 43215
Nashville, TN
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Phase II Randomized Trial of Gemcitabine and Cisplatin With or Without Cetuximab in Patients With Urothelial Carcinoma
Status: Enrolling
Updated: 8/28/2015
Vanderbilt-Ingram Cancer Center
334
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Phase II Randomized Trial of Gemcitabine and Cisplatin With or Without Cetuximab in Patients With Urothelial Carcinoma
Status: Enrolling
Updated:  8/28/2015
University of Texas M.D. Anderson Cancer Center
995
mi
from 43215
Houston, TX
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Phase II Randomized Trial of Gemcitabine and Cisplatin With or Without Cetuximab in Patients With Urothelial Carcinoma
Status: Enrolling
Updated: 8/28/2015
University of Texas M.D. Anderson Cancer Center
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Phase II Randomized Trial of Gemcitabine and Cisplatin With or Without Cetuximab in Patients With Urothelial Carcinoma
Status: Enrolling
Updated:  8/28/2015
University of Utah, Huntsman Cancer Institute
1511
mi
from 43215
Salt Lake City, UT
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Phase II Randomized Trial of Gemcitabine and Cisplatin With or Without Cetuximab in Patients With Urothelial Carcinoma
Status: Enrolling
Updated: 8/28/2015
University of Utah, Huntsman Cancer Institute
1511
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Phase II Randomized Trial of Gemcitabine and Cisplatin With or Without Cetuximab in Patients With Urothelial Carcinoma
Status: Enrolling
Updated:  8/28/2015
Univ of Washington
2006
mi
from 43215
Seattle, WA
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Phase II Randomized Trial of Gemcitabine and Cisplatin With or Without Cetuximab in Patients With Urothelial Carcinoma
Status: Enrolling
Updated: 8/28/2015
Univ of Washington
2006
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer
Phase II Trial of Neoadjuvant Dose Dense Gemcitabine and Cisplatin In Muscle Invasive Bladder Cancer
Status: Enrolling
Updated:  9/2/2015
Thomas Jefferson University [Kimmel Cancer Center]
416
mi
from 43215
Philadelphia, PA
Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer
Phase II Trial of Neoadjuvant Dose Dense Gemcitabine and Cisplatin In Muscle Invasive Bladder Cancer
Status: Enrolling
Updated: 9/2/2015
Thomas Jefferson University [Kimmel Cancer Center]
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer
Phase II Trial of Neoadjuvant Dose Dense Gemcitabine and Cisplatin In Muscle Invasive Bladder Cancer
Status: Enrolling
Updated:  9/2/2015
Fox Chase Cancer Center
420
mi
from 43215
Philadelphia, PA
Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer
Phase II Trial of Neoadjuvant Dose Dense Gemcitabine and Cisplatin In Muscle Invasive Bladder Cancer
Status: Enrolling
Updated: 9/2/2015
Fox Chase Cancer Center
420
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Efficacy Study of a Urine DEK ELISA for Diagnosis of Bladder Cancer
A Multi-Center Study to Evaluate the Safety and Efficacy of a Urine DEK ELISA in Diagnosis of Subjects With Bladder Cancer
Status: Enrolling
Updated:  9/22/2015
Staten Island University Hospital
473
mi
from 43215
Staten Island, NY
Efficacy Study of a Urine DEK ELISA for Diagnosis of Bladder Cancer
A Multi-Center Study to Evaluate the Safety and Efficacy of a Urine DEK ELISA in Diagnosis of Subjects With Bladder Cancer
Status: Enrolling
Updated: 9/22/2015
Staten Island University Hospital
473
mi
from 43215
Staten Island, NY
Click here to add this to my saved trials
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
Brief Physician-Initiated Quit Smoking Strategies for Clinical Oncology Settings
Status: Enrolling
Updated:  10/6/2015
Fox Chase Cancer Center
420
mi
from 43215
Philadelphia, PA
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
Brief Physician-Initiated Quit Smoking Strategies for Clinical Oncology Settings
Status: Enrolling
Updated: 10/6/2015
Fox Chase Cancer Center
420
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Iressa and Taxotere Study in Patients With Metastatic Urothelial Cancer
Phase II Trial of Weekly Docetaxel (Taxotere) Vs. Weekly Docetaxel in Combination With ZD1839 (Iressa®) As Consolidation Therapy For Metastatic Urothelial Cancer Following Maximal Response To Multi-Agent Chemotherapy
Status: Enrolling
Updated:  10/8/2015
University of Texas M.D. Anderson Cancer Center
995
mi
from 43215
Houston, TX
Iressa and Taxotere Study in Patients With Metastatic Urothelial Cancer
Phase II Trial of Weekly Docetaxel (Taxotere) Vs. Weekly Docetaxel in Combination With ZD1839 (Iressa®) As Consolidation Therapy For Metastatic Urothelial Cancer Following Maximal Response To Multi-Agent Chemotherapy
Status: Enrolling
Updated: 10/8/2015
University of Texas M.D. Anderson Cancer Center
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated:  10/13/2015
University of Alabama at Birmingham, Comprehensive Cancer Center
492
mi
from 43215
Birmingham, AL
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated: 10/13/2015
University of Alabama at Birmingham, Comprehensive Cancer Center
492
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated:  10/13/2015
Huntsville Hospital System
411
mi
from 43215
Huntsville, AL
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated: 10/13/2015
Huntsville Hospital System
411
mi
from 43215
Huntsville, AL
Click here to add this to my saved trials
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated:  10/13/2015
Comprehensive Cancer Institute of Huntsville
409
mi
from 43215
Huntsville, AL
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated: 10/13/2015
Comprehensive Cancer Institute of Huntsville
409
mi
from 43215
Huntsville, AL
Click here to add this to my saved trials
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated:  10/13/2015
MBCCOP - Gulf Coast
702
mi
from 43215
Mobile, AL
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated: 10/13/2015
MBCCOP - Gulf Coast
702
mi
from 43215
Mobile, AL
Click here to add this to my saved trials
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated:  10/13/2015
Alabama Oncology, LLC
555
mi
from 43215
Montgomery, AL
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated: 10/13/2015
Alabama Oncology, LLC
555
mi
from 43215
Montgomery, AL
Click here to add this to my saved trials
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated:  10/13/2015
Radiation Oncology Associates of West Alabama
534
mi
from 43215
Tuscallosa, AL
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated: 10/13/2015
Radiation Oncology Associates of West Alabama
534
mi
from 43215
Tuscallosa, AL
Click here to add this to my saved trials
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated:  10/13/2015
Foundation for Cancer Research and Education
1662
mi
from 43215
Phoenix, AZ
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated: 10/13/2015
Foundation for Cancer Research and Education
1662
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated:  10/13/2015
Mount Diablo Medical Center
2084
mi
from 43215
Concord, CA
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated: 10/13/2015
Mount Diablo Medical Center
2084
mi
from 43215
Concord, CA
Click here to add this to my saved trials
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated:  10/13/2015
Cancer Center and Beckman Research Institute, City of Hope
1955
mi
from 43215
Duarte, CA
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated: 10/13/2015
Cancer Center and Beckman Research Institute, City of Hope
1955
mi
from 43215
Duarte, CA
Click here to add this to my saved trials
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated:  10/13/2015
California Cancer Center
1986
mi
from 43215
Fresno, CA
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated: 10/13/2015
California Cancer Center
1986
mi
from 43215
Fresno, CA
Click here to add this to my saved trials
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated:  10/13/2015
Saint Agnes Cancer Center
1986
mi
from 43215
Fresno, CA
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated: 10/13/2015
Saint Agnes Cancer Center
1986
mi
from 43215
Fresno, CA
Click here to add this to my saved trials
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated:  10/13/2015
Sutter Health West Cancer Research Group
2109
mi
from 43215
Greenbrae, CA
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated: 10/13/2015
Sutter Health West Cancer Research Group
2109
mi
from 43215
Greenbrae, CA
Click here to add this to my saved trials
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated:  10/13/2015
Loma Linda University Medical Center
1919
mi
from 43215
Loma Linda, CA
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated: 10/13/2015
Loma Linda University Medical Center
1919
mi
from 43215
Loma Linda, CA
Click here to add this to my saved trials
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated:  10/13/2015
Veterans Affairs Medical Center - Long Beach
1972
mi
from 43215
Long Beach, CA
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated: 10/13/2015
Veterans Affairs Medical Center - Long Beach
1972
mi
from 43215
Long Beach, CA
Click here to add this to my saved trials
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated:  10/13/2015
USC/Norris Comprehensive Cancer Center and Hospital
1972
mi
from 43215
Los Angeles, CA
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated: 10/13/2015
USC/Norris Comprehensive Cancer Center and Hospital
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated:  10/13/2015
Jonsson Comprehensive Cancer Center at UCLA
1982
mi
from 43215
Los Angeles, CA
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated: 10/13/2015
Jonsson Comprehensive Cancer Center at UCLA
1982
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated:  10/13/2015
CCOP - Bay Area Tumor Institute
2098
mi
from 43215
Oakland, CA
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated: 10/13/2015
CCOP - Bay Area Tumor Institute
2098
mi
from 43215
Oakland, CA
Click here to add this to my saved trials
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated:  10/13/2015
Huntington Cancer Center
1965
mi
from 43215
Pasadena, CA
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated: 10/13/2015
Huntington Cancer Center
1965
mi
from 43215
Pasadena, CA
Click here to add this to my saved trials
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated:  10/13/2015
Cancer Care Center
1944
mi
from 43215
Pomona, CA
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated: 10/13/2015
Cancer Care Center
1944
mi
from 43215
Pomona, CA
Click here to add this to my saved trials
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated:  10/13/2015
Radiation Oncology Center - Sacramento
2042
mi
from 43215
Sacramento, CA
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated: 10/13/2015
Radiation Oncology Center - Sacramento
2042
mi
from 43215
Sacramento, CA
Click here to add this to my saved trials
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated:  10/13/2015
Radiation Medical Group, Inc.
1951
mi
from 43215
San Diego, CA
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
Status: Enrolling
Updated: 10/13/2015
Radiation Medical Group, Inc.
1951
mi
from 43215
San Diego, CA
Click here to add this to my saved trials